# Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-and-molecular-features-of-kras-mutated-lung-cancer-patients-treated/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Dan Zhao,Haiqing Li,Isa Mambetsariev,Tamara Mirzapoiazova,Chen Chen,Jeremy Fricke,Prakash Kulkarni,Victoria Villaflor,Leonidas Arvanitis,Stanley R. Hamilton,Michelle Afkhami,Raju Pillai,Brian Armstrong,Loretta Erhunmwunsee,Erminia Massarelli,Martin Sattler,Arya Amini,Ravi Salgia |
| Citations | 23 |
| DOI | 10.3390/cancers14194933 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.mdpi.com/2072-6694/14/19/4933/pdf?version=1665384506 |
| OpenAlex ID | https://openalex.org/W4303685359 |
| PMID | 36230855 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Leonidas Arvanitis](https://scholariq.org/researchers/leonidas-arvanitis/)

## Paper journal

- [Cancers](https://scholariq.org/journals/cancers/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.